Published in Circulation on January 18, 2005
Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis. Circulation (2015) 2.49
CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis. JACC Cardiovasc Imaging (2014) 1.57
Cardiovascular magnetic resonance for amyloidosis. Heart Fail Rev (2015) 1.00
The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy. Heart Fail Rev (2011) 0.90
Cardiac amyloidosis responding to bortezomib: case report and review of literature. Curr Cardiol Rev (2009) 0.90
Amyloidosis of the heart and respiratory system. Eur Radiol (2006) 0.80
Author reply--an unusual case of cardiac amyloidosis. J Gen Intern Med (2007) 0.75
Cardioverter-defibrillator implantation in myeloma-associated cardiac amyloidosis. Exp Clin Cardiol (2013) 0.75
Application of cardiac magnetic resonance imaging in cardiomyopathy. Curr Heart Fail Rep (2008) 0.75
Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation (2005) 5.85
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol (2005) 5.64
Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation (2006) 4.98
High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med (2004) 4.05
The amyloidogenic V122I transthyretin variant in elderly black Americans. N Engl J Med (2015) 3.36
Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study. Circulation (2008) 2.77
The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation . J Am Coll Cardiol (2013) 2.76
Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med (2005) 2.33
Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). Eur Heart J (2007) 2.11
Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol (2006) 2.08
Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. JACC Cardiovasc Imaging (2012) 2.03
Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation (2009) 2.02
Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation (2009) 2.01
Prognostic significance of strain Doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging (2010) 1.93
Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc Imaging (2009) 1.93
Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging (2014) 1.91
Stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease. Circulation (2013) 1.87
Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient's sex. JACC Cardiovasc Imaging (2011) 1.83
Left atrial passive emptying function during dobutamine stress MR imaging is a predictor of cardiac events in patients with suspected myocardial ischemia. JACC Cardiovasc Imaging (2011) 1.77
Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation (2003) 1.71
Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis. Clin Lymphoma (2003) 1.69
Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis. Chest (2003) 1.68
Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions. JACC Cardiovasc Imaging (2013) 1.65
Two-dimensional assessment of right ventricular function: an echocardiographic-MRI correlative study. Echocardiography (2007) 1.51
Myocardial infarction triggers chronic cardiac autoimmunity in type 1 diabetes. Sci Transl Med (2012) 1.49
Diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis (2010) 1.46
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation. Blood (2004) 1.38
T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Circ Cardiovasc Imaging (2013) 1.35
Strong cardiovascular prognostic implication of quantitative left atrial contractile function assessed by cardiac magnetic resonance imaging in patients with chronic hypertension. J Cardiovasc Magn Reson (2011) 1.21
Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Coll Cardiol (2007) 1.21
Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis. Am Heart J (2009) 1.20
CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging (2013) 1.17
Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation. Biol Blood Marrow Transplant (2010) 1.13
Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation. J Am Heart Assoc (2013) 1.13
Beneficial effects of eplerenone versus hydrochlorothiazide on coronary circulatory function in patients with diabetes mellitus. J Clin Endocrinol Metab (2007) 1.09
"Bendopnea" or "kamptopnea?": Some thoughts on terminology and mechanisms. JACC Heart Fail (2014) 1.09
Cardiac amyloidosis. Circulation (2012) 1.08
Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS). Am Heart J (2012) 1.07
Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish. Am J Physiol Heart Circ Physiol (2013) 1.06
Current perspectives on cardiac amyloidosis. Am J Physiol Heart Circ Physiol (2011) 1.04
Images in cardiovascular medicine. Intramural atrial hematoma after catheter ablation for atrial tachyarrhythmias. Circulation (2007) 1.03
Insulin resistance, subclinical left ventricular remodeling, and the obesity paradox: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol (2013) 1.02
Longitudinal myocardial velocity gradient derived from pulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction. J Am Soc Echocardiogr (2004) 1.01
Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging. J Cardiovasc Magn Reson (2006) 1.01
Cardiac amyloidosis mimicking hypertrophic cardiomyopathy with obstruction: treatment with disopyramide. Circulation (2012) 1.01
Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. Circulation (2014) 1.00
Quantitative relationship between coronary calcium content and coronary flow reserve as assessed by integrated PET/CT imaging. Eur J Nucl Med Mol Imaging (2009) 1.00
Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy. Am J Cardiol (2011) 0.99
A 1.5T MRI-conditional 12-lead electrocardiogram for MRI and intra-MR intervention. Magn Reson Med (2014) 0.99
Magnetic resonance imaging of complex partial anomalous pulmonary venous return in adults. Circulation (2014) 0.99
Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines. Am J Cardiol (2012) 0.99
Does iron overload really matter in stem cell transplantation? Am J Hematol (2012) 0.99
MR myocardial perfusion imaging. Radiology (2013) 0.99
Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients. J Cardiovasc Magn Reson (2013) 0.98
Images in cardiovascular medicine. Löffler endocarditis presenting with recurrent polymorphic ventricular tachycardia diagnosed by cardiac magnetic resonance imaging. Circulation (2010) 0.98
Measuring myocardial scar by CMR. JACC Cardiovasc Imaging (2011) 0.97
The utility of cardiovascular magnetic resonance in constrictive pericardial disease. Cardiol Rev (2009) 0.96
Multimodality imaging in the assessment of myocardial viability. Heart Fail Rev (2011) 0.94
Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis. Amyloid (2005) 0.93
Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am J Cardiol (2002) 0.92
Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy. Am J Cardiol (2012) 0.92
Prognostic significance of ultrasound myocardial tissue characterization in patients with cardiac amyloidosis. Circulation (2002) 0.91
Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: a case report and review of the literature. Dermatol Online J (2012) 0.91
Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity. Basic Res Cardiol (2013) 0.91
The increasing need for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Mayo Clin Proc (2004) 0.91
Myocardial tissue remodeling in adolescent obesity. J Am Heart Assoc (2013) 0.90
Effect of cardiac stem cells on left-ventricular remodeling in a canine model of chronic myocardial infarction. Circ Heart Fail (2012) 0.88
Cerebral abscess due to persistent left superior vena cava draining into the left atrium. Circulation (2011) 0.88
Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA. J Nucl Cardiol (2013) 0.85
Is elevated plasma B-natriuretic peptide in amyloidosis simply a function of the presence of heart failure? Am J Cardiol (2005) 0.85
Identification of a novel transthyretin Thr59Lys/Arg104His. A case of compound heterozygosity in a Chinese patient diagnosed with familial transthyretin amyloidosis. Amyloid (2002) 0.85
Is magnetic resonance image guidance the key to opening chronic total occlusions? Circulation (2006) 0.85
Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging. J Nucl Med (2013) 0.85
Severe hypercalcaemia mimicking acute myocardial infarction. Clin Med (2009) 0.84
Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis. Br J Haematol (2002) 0.84
Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus. Am J Cardiol (2013) 0.84
Comparison of the strain Doppler echocardiographic features of familial amyloid polyneuropathy (FAP) and light-chain amyloidosis. Am J Cardiol (2005) 0.83
Ventricular restraint therapy for heart failure: the right ventricle is different from the left ventricle. J Thorac Cardiovasc Surg (2010) 0.83
Cost-effectiveness analysis for imaging techniques with a focus on cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2013) 0.83
Evaluation of malposition of the branch pulmonary arteries using cardiovascular computed tomography angiography. Eur Radiol (2014) 0.82
Optimal imaging strategies to assess coronary blood flow and risk for patients with coronary artery disease. Curr Opin Cardiol (2008) 0.81
Images in cardiovascular medicine. Initial presentation of an accessory left ventricle in a patient with syncope. Circulation (2010) 0.81
Computed tomography for assessment of cardiac chambers, valves, myocardium and pericardium. Cardiol Clin (2003) 0.81
Images in cardiovascular medicine. Myocardial fibroma in gorlin syndrome by cardiac magnetic resonance imaging. Circulation (2006) 0.81
Assessment of myocardial ischemia with cardiovascular magnetic resonance. Prog Cardiovasc Dis (2011) 0.81
Cardiac MRI for myocardial ischemia. Methodist Debakey Cardiovasc J (2013) 0.80
Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T]). Am J Cardiol (2003) 0.80
Feasibility study of electrocardiographic and respiratory gated, gadolinium enhanced magnetic resonance angiography of pulmonary veins and the impact of heart rate and rhythm on study quality. J Cardiovasc Magn Reson (2014) 0.80
Optimized ventricular restraint therapy: adjustable restraint is superior to standard restraint in an ovine model of ischemic cardiomyopathy. J Thorac Cardiovasc Surg (2012) 0.80
Apical hypertrophic cardiomyopathy: diagnosed by cardiac magnetic resonance imaging. Tex Heart Inst J (2006) 0.80
Parvovirus b19-induced myocarditis mimicking acute myocardial infarction: clarification of diagnosis by cardiac magnetic resonance imaging. Circulation (2010) 0.80
Clinical application of cardiac CMR. Rev Cardiovasc Med (2009) 0.79
Infarct haemorrhage detected by cardiac magnetic resonance imaging: are we seeing the latest culprit in adverse left ventricular remodelling? Eur Heart J (2009) 0.79
Images in cardiovascular medicine: solitary fatty infiltration within the left ventricle detected by cardiac magnetic resonance imaging in a patient presenting with ventricular tachycardia. Circulation (2009) 0.79
The diagnosis and typing of cardiac amyloidosis. Amyloid (2003) 0.79
Unifying statistical classification and geodesic active regions for segmentation of cardiac MRI. IEEE Trans Inf Technol Biomed (2008) 0.79
Cardiac T(1) imaging. Top Magn Reson Imaging (2014) 0.79
COCATS 4 Task Force 8: Training in Cardiovascular Magnetic Resonance Imaging. J Am Coll Cardiol (2015) 0.78
Myocardial blood flow quantification for evaluation of coronary artery disease by positron emission tomography, cardiac magnetic resonance imaging, and computed tomography. Curr Cardiol Rep (2014) 0.78